Fresenius SE & Co. KGaA (FSNUF)

OTCMKTS · Delayed Price · Currency is USD
41.01
+1.01 (2.52%)
At close: Mar 5, 2025
52.54%
Market Cap 24.32B
Revenue (ttm) 22.60B
Net Income (ttm) 487.63M
Shares Out n/a
EPS (ttm) 0.87
PE Ratio 49.87
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 643
Average Volume 2,952
Open 41.01
Previous Close 40.00
Day's Range 41.01 - 41.01
52-Week Range 25.77 - 37.08
Beta 1.06
RSI 62.43
Earnings Date May 7, 2025

About Fresenius SE & Co. KGaA

Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed segments. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, dialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients; e... [Read more]

Sector Healthcare
Founded 1912
Employees 193,865
Stock Exchange OTCMKTS
Ticker Symbol FSNUF
Full Company Profile

Financial Performance

Financial numbers in EUR Financial Statements

News

Fresenius: Turnaround For Company, Stock Price

Fresenius SE's restructuring and dividend reinstatement signal strong growth. Read why FSNUF stock may not be a long-term buy despite short-term gains.

12 days ago - Seeking Alpha

Health Care Roundup: Market Talk

Find insight on Bayer, Sandoz, Fresenius and more in the latest Market Talks covering Health Care.

23 days ago - The Wall Street Journal

Fresenius SE & Co KGaA (FSNUF) Full Year 2024 Earnings Call Highlights: Strong Growth and ...

Fresenius SE & Co KGaA (FSNUF) Full Year 2024 Earnings Call Highlights: Strong Growth and Strategic Advancements

4 weeks ago - GuruFocus

Germany has homework to do, Fresenius CEO says

Fresenius CEO Michael Sen discusses the company's latest financial results and the state of the German economy.

4 weeks ago - CNBC

Fresenius Sees Hospital Costs Holding Back Higher Profit in 2025

Fresenius SE expects profit growth to slow in 2025 as cost pressures in its hospital business rise, partly due to the expiration of government funding.

4 weeks ago - Financial Post

It's clear the old world order has come to an end, says Fresenius CEO

Michael Sen, CEO of Fresenius, discusses geopolitics and the healthcare industry.

2 months ago - CNBC

Fresenius: The Signs Of A Significant Turnaround Are Getting Clearer And Clearer

Fresenius is showing significant upside, with a 25% RoR since early 2024, driven by strong earnings growth and strategic execution. The company's turnaround is evident with improved EPS, reduced lever...

3 months ago - Seeking Alpha

Siemens Taps Ex-Nestle CEO Schneider for Board, Potential Chair

Siemens AG is proposing that Mark Schneider, former chief executive officer of Nestle SA and Fresenius SE, join its supervisory board with the plan of later becoming chairman.

3 months ago - BNN Bloomberg

Fresenius SE Raises Guidance After Strong Kabi, Helios Performances

The healthcare company lifted its full-year guidance after a robust third quarter driven by Kabi and good organic growth at Helios.

5 months ago - The Wall Street Journal

Fresenius SE Raises Guidance After Strong Kabi, Helios Performances

The healthcare company lifted its full-year guidance after a robust third quarter driven by Kabi and good organic growth at Helios.

5 months ago - WSJ

Fresenius SE & Co. reports Q3 results

5 months ago - Seeking Alpha

Fresenius: Showing Signs Of Recovery, We Have Dawn

Fresenius is showing early signs of recovery, with improved profitability and simplified structure. Read why FSNUF stock remains a Buy for long-term investors.

7 months ago - Seeking Alpha

Fresenius SE & Co. KGaA (FSNUF) Q2 2024 Earnings Call Transcript

Fresenius SE & Co. KGaA (OTCPK:FSNUF) Q2 2024 Earnings Conference Call July 31, 2024 7:30 AM ET Company Participants Markus Georgi - Head of Investor Relations. Michael Sen - Chief Executive Officer S...

8 months ago - Seeking Alpha

Fresenius: It's Darkest Before The Dawn

Fresenius, a German healthcare company, has the potential for significant growth and a near-term turnaround. The company is in the midst of a restructuring and has met its revenue and earnings targets...

11 months ago - Seeking Alpha

Fresenius SE: Hoping For The Turnaround In 2024

Fresenius reported mediocre results and suspended the dividend this year, but management is optimistic for fiscal 2024. The company will focus on reducing debt levels in 2024 and the deconsolidation o...

1 year ago - Seeking Alpha

Fresenius SE & Co. KGaA (FSNUF) Q4 2023 Earnings Call Transcript

Fresenius SE & Co. KGaA (FSNUF) Q4 2023 Earnings Call Transcript

1 year ago - Seeking Alpha

Healthcare group Fresenius tops Q4 operating profit expectations

Fresenius reported a bigger-than-expected 13% jump in fourth-quarter operating profit on Wednesday, citing good earnings development across its businesses and progress in the operational turnaround at...

1 year ago - Reuters

Fresenius perfectly positioned to combat health inequality, says CEO

Michael Sen, CEO at Fresenius, explains what the company is doing to help close the health care gap.

1 year ago - CNBC International TV